Journal Article

Tinnitus reduction after active bone-conduction implantation in patients with single-sided deafness: a prospective multicenter study

Park, Shi Nae, Lee, Kyu-Yup, Cho, Hyong-Ho, Ha, Jungho, Moon, Il Joon, Choi, Jae Young, Oh, Jeong-Hoon, Park, Moo Kyun, Seo, Jae-Hyun, Kim, Hantai, Choung, Yun-Hoon, Park, Hong Ju, Jang, Jeong Hun, Jung, Jinsei, Jung, Jae Yun, Song, Jae-Jin, Lee, Chi Kyou, Lee, Il-Woo

2024

Overview

Purpose Single-sided deafness (SSD) presents significant challenges for patients, including compromised sound localization, reduced speech recognition, and often, tinnitus. These issues are typically addressed using interventions such as cochlear implantation (CI) and bone conduction implant (BCI). However, evidence regarding the efficacy of BCI in reducing tinnitus in SSD patients remains limited. This study explored the ability of a novel active transcutaneous BCI (Bonebridge BCI602) to alleviate tinnitus in SSD patients. Study design Prospective cohort multicenter study. Setting Tertiary referral hospitals. Methods A prospective multicenter study of 30 SSD patients was conducted. The patients were divided into two groups: those with ( n  = 19) and without ( n  = 11) tinnitus. Audiometric assessments, subjective questionnaires including the Abbreviated Profile of Hearing Aid Benefit (APHAB) and the Bern Benefit in Single-Sided Deafness (BBSS), and tinnitus evaluations with the Tinnitus Handicap Inventory (THI) and tinnitogram were conducted before and after BCI surgery. Results THI scores after surgery were significantly reduced in SSD patients with tinnitus. Subjective satisfaction improved in both the tinnitus and non-tinnitus groups; however, the former group exhibited a significantly greater improvement in the APHAB questionnaire score. According to tinnitograms, the loudness of tinnitus decreased, particularly in patients with ipsilateral tinnitus. Patients with residual hearing had greater reductions in their THI scores. However, three patients without residual hearing had a relative worsening of tinnitus after surgery. Conclusion The Bonebridge BCI602 effectively reduced tinnitus in SSD patients, particularly in those with residual hearing. Subjective satisfaction improved in both the tinnitus and non-tinnitus groups. These findings demonstrate the therapeutic potential of BCI for managing SSD and associated tinnitus.

• Publisher: Springer Berlin Heidelberg,Springer Nature B.V
• Subject: Adult / Aged / Bone Conduction / Female / Head and Neck Surgery / Hearing Aids / Hearing Loss, Unilateral - physiopathology / Hearing Loss, Unilateral - rehabilitation / Hearing Loss, Unilateral - surgery / Humans / Male / Medicine / Medicine & Public Health / Middle Aged / Neurosurgery / Otology / Otorhinolaryngology / Prospective Studies / Surveys and Questionnaires / Tinnitus - physiopathology / Tinnitus - surgery / Treatment Outcome